HUIPF
Hydrogen Utopia International PLC
Mentions (24Hr)
0.00% Today
Reddit Posts
Mentions
I'm very convinced of HUIPF and SNSE as long-term multi-baggers.
Stocks I recommend but haven't mentioned much: **PYXS** (first-in-concept with a smallish, locked-up float awaiting Q4 data release) and **INO** (developer of DNA immunotherapies for HPV-linked tumours expecting imminent approval). **CELZ** is looking like a godsend, developing cell lines for diabetes and chronic back pain. Topline data is expected by May 21st 2026 but its cash runway can last until next October. A rare chance to accumulate. Stocks I recommend and have mentioned a lot: **PLSR** (poised to dominate global supply of a rare and eldritch isotope); **SLS** (producing the closest thing we have to a generalised cancer survivability drug), and **HUI** (a.k.a. **HUIPF**), pursuing green hydrogen recovery from petrochemical and construction industries in the Middle East. I also called out ASX:**EOS**, which is up 13% in five days and has plenty of room to run. You all know **INTS** already. Never do your own research. The value of your investment can go up as well as further up. 110% of retail accounts make mad racks from tips off Reddit. Sell your wife's jewellery right now. Obey the voices. Not financial advice.
Can't recommend PYXS or AZTR enough for Q4 2024 biotech opportunities. The real star's still SLS, but PYXS and AZTR have explosive potential. It's also a great time to be accumulating INTS and FBLG. I put FBLG on a watchlist a month ago and it's up c. 50%. Outside of biotech, HUIPF and PLSR are primed for explosive growth - conceptually and financially. I'm still in awe at how committed HUIPF's CEO appears to be. She used her own stake as collateral for a credit line rather than dilute.
WWR is in a very good position to build graphite mine and production facilities. I know people forgot about them after the critical minerals rally, but don't underestimate their position. PLSR plans ten new appraisal wells, which is a bit insane but mostly funded by warrants that have already been exercised. With an 1,000% increase in land assets near their Topaz project (on continuant geology), it is very unlikely any near-future appraisals will underwhelm. SLS is going to help me buy an island. No doubt whatsoever. Its drug (GPS) is for survivability, and data release is triggered by the eightieth patient death. The longer it takes to release data, the better the chance of that data being good. It's already a year overdue. AZTR is also in my port. No idea what its chances of good Phase II results are (haven't read the science), but it's such a small float a stiff breeze could trigger a multi-bag run. Still bullish on HUI (HUIPF) too. There's something very attractive about the company's recent momentum and unique strategic vision. They know *why* past stock performance is poor and seem to know exactly what to do to address it. Huge float, but mostly locked-up. Underrated potential for swings.